PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.03%
Negative net income growth while CRWV stands at 7.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.61%
Less D&A growth vs. CRWV's 26.15%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-83.45%
Negative yoy deferred tax while CRWV stands at 3.70%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
6.05%
SBC growth while CRWV is negative at -21.18%. John Neff would see competitor possibly controlling share issuance more tightly.
130.75%
Slight usage while CRWV is negative at -110.52%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
200.20%
AR growth while CRWV is negative at -35.57%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-396.46%
Negative yoy inventory while CRWV is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-143.28%
Both negative yoy AP, with CRWV at -663.96%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-165.97%
Negative yoy usage while CRWV is 112.72%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
103.42%
Well above CRWV's 23.14%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-14.22%
Both yoy CFO lines are negative, with CRWV at -510.76%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
16.44%
Some CapEx rise while CRWV is negative at -74.30%. John Neff would see competitor possibly building capacity while we hold back expansions.
-64.41%
Negative yoy acquisition while CRWV stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-51.47%
Negative yoy purchasing while CRWV stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
103.41%
We have some liquidation growth while CRWV is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
170.80%
Growth well above CRWV's 202.79%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
75.53%
We have mild expansions while CRWV is negative at -70.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-150.00%
Both yoy lines negative, with CRWV at -200.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
38.64%
Stock issuance far above CRWV's 4.88%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-6.02%
We cut yoy buybacks while CRWV is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.